After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Zai Lab Limited ADR is $4.16B. A total of 0.72 million shares were traded on the day, compared to an average of 1.16M shares.
In the most recent transaction, Chen Yajing sold 9,618 shares of ZLAB for 30.00 per share on Jun 02 ’25. After the transaction, the Chief Financial Officer now owns 17,429 company shares. In a previous transaction on Jun 02 ’25, Chen Yajing bought 9,618 shares at 30.00 per share.
Among the insiders who sold shares, Du Ying disposed of 50,000 shares on May 13 ’25 at a per-share price of $28.57. This resulted in the Chairperson & CEO holding 479,851 shares of ZLAB after the transaction. In another insider transaction, Du Ying sold 46,389 shares at $28.09 per share on May 14 ’25. Company shares held by the Chairperson & CEO now total 479,851.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, ZLAB has a high of $39.77 and a low of $16.01.
As of this writing, ZLAB has an earnings estimate of -$0.42 per share for the current quarter. EPS was calculated based on a consensus of 5.0 estimates, with a high estimate of -$0.31 per share and a lower estimate of -$0.56.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. ZLAB’s latest balance sheet shows that the firm has $1.41B in Cash & Short Term Investments as of fiscal 2021. There were $15.54M in debt and $192.90M in liabilities at the time. Its Book Value Per Share was $7.48, while its Total Shareholder’s Equity was $1.38B.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ZLAB is Buy with a score of 4.75.
